Healthcare is moving its focus from the sheer quantity of real-world data (RWD) to quality, prioritizing project-specific solutions, flexible platforms,…
By analyzing real-world data, digital health organizations can gain insight into actual costs, measure outcomes, and build optimized networks that…
Healthcare is moving its focus from the sheer quantity of real-world data (RWD) to quality, prioritizing project-specific solutions, flexible platforms,…
By analyzing real-world data, digital health organizations can gain insight into actual costs, measure outcomes, and build optimized networks that…
Routine immunizations are essential for public health, so why are vaccination rates in the US on the decline? Addressing social,…
A new whitepaper examines the key considerations researchers must understand to link data successfully.
Studies highlight how patients' socioeconomic backgrounds can significantly influence their health outcomes. Dedicated datasets highlight those differences to help improve…
How longitudinal, closed claims data is advancing regulatory, epidemiology, and health economics and outcomes research (HEOR).
The FDA has released final draft recommendations for using real-world data and evidence in drug development.
Award-winning supplier of high-quality B2B data lists, database cleansing and analysis, with expert insights in epidemiology, regulatory approvals, and HEOR.
Read More